George Church spin­out de­vel­op­ing ge­nom­i­cal­ly re­cod­ed or­gan­isms cuts most em­ploy­ees

GRO Bio­sciences, a small but am­bi­tious biotech start­up at­tempt­ing to cre­ate nov­el pro­tein drugs from ge­net­i­cal­ly mod­i­fied bac­te­ria, has cut most of its staff af­ter …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER